Skip to content

Erector Spinae Plane Block Versus Retrolaminar Block for Analgesia in Percutaneous Nephrolithotomy

Ultrasound-guided Erector Spinae Plane Block Versus Retrolaminar Block for Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06710444
Enrollment
120
Registered
2024-11-29
Start date
2024-12-01
Completion date
2025-04-01
Last updated
2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia, Pain Management, PCNL, Regional Anesthesia Block

Keywords

Postoperative, Analgesia, Pain, Erector Spinae, Retrolaminar, Block, PCNL

Brief summary

The study will investigate the effects of ultrasound-guided ESPB and RLB on intraoperative and postoperative analgesia in patients undergoing PCNL to identify a safe and effective regional block method for postoperative analgesia

Detailed description

All the patients will be blinded to the intervention received in this study. All patients will receive standard general anesthesia technique with endotracheal intubation and muscle paralysis. Postoperatively, all patients will receive analgesia in the form of non-steroidal anti-inflammatory drugs and paracetamol. In case the VAS scores exceeded 4 in any group, the patients will receive rescue analgesia with 25 mg IV meperidine. In both groups, the ESPB and RLB will be performed after induction of general anesthesia using portable ultrasound device.

Interventions

PROCEDUREultrasound-guided retrolaminar plane block

RLB

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patients scheduled for PCNL

Exclusion criteria

* daily consumption of analgesics * allergy to local anesthetics * liver dysfunction * infection or previous surgery in the vertebral region. * patient refusal * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
measurement of visual analogue scoreafter the surgery average 48 hours postoperativemeasurement of visual analogue score during rest and movement. The Score range from 0-10. 0 means no pain and 10 indicates the worst pain ever

Secondary

MeasureTime frameDescription
postoperative additional analgesic requirementafter the surgery average 48 hours postoperativeTotal cumulative analgesic requirement dose
assessing the patient satisfaction by a the short assessment of patient satisfaction score (SAPS)after the surgery average 48 hours postoperativefrom 0 to 28, where 0 is so dissatisfied and 28 means very satisfied
Time to ambulateafter the surgery average 12 hours postoperativeTime from discharge from the operating theatre to start to ambulate
presence of postoperative nausea and vomitingafter the surgery average 48 hours postoperativeNumber of postoperative nausea and vomiting

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026